title: Response to Letter to the Editor: HbA1c as a screening tool for cystic fibrosis related diabetes: Response to letters by Widger et al. and Schnyder et al.
authors.affiliation: National Heart and Lung Institute, Imperial College, London, United Kingdom; Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom.
authors.forename: Juliana C
authors.initials: JC
authors.lastname: Burgess
authors.affiliation: Endocrinology and Diabetes Department, Chelsea Children's Hospital, Chelsea and Westminster NHS Healthcare Trust, London, United Kingdom.
authors.forename: Nicola
authors.initials: N
authors.lastname: Bridges
authors.affiliation: Medical Statistician, Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom.
authors.forename: Banya
authors.initials: B
authors.lastname: Winston
authors.affiliation: Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom.
authors.forename: Khin M
authors.initials: KM
authors.lastname: Gyi
authors.affiliation: National Heart and Lung Institute, Imperial College, London, United Kingdom; Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom.
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Hodson
authors.affiliation: Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom.
authors.forename: Diana
authors.initials: D
authors.lastname: Bilton
authors.affiliation: National Heart and Lung Institute, Imperial College, London, United Kingdom; Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom. Electronic address: n.simmonds@imperial.ac.uk.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Simmonds
mesh_terms: D003550:Cystic Fibrosis; D003920:Diabetes Mellitus / Q000175:diagnosis*; D006801:Humans